Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
7571PS27Q00015
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
R499
Additional Details
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Financial Resources (ASFR) and the OMAS Strategic Buying Center - Professional Services, is soliciting qualified small businesses to provide executive-level subject matter expertise in patient advocacy for the National Institute of Neurological Disorders and Stroke (NINDS) Ultra-rare Gene-based Therapy (URGenT) Network. This opportunity, posted under solicitation number 7571PS27Q00015, is a combined synopsis/solicitation for commercial services, set aside exclusively for small business concerns under NAICS code 541690 (Other Scientific and Technical Consulting Services), with a small business size standard of $19 million.
**Purpose and Scope**
The primary objective of this procurement is to engage a Senior Advisor Subject Matter Expert (SME) with substantial experience in drug discovery, development, and patient advocacy. The selected contractor will provide strategic feedback and technical guidance to NINDS program leadership, specifically supporting drug discovery and development projects within the URGenT portfolio. The SME will serve as a member of the URGenT External Counselor Board (ECB), which is tasked with offering high-level strategic direction on URGenT projects and, as needed, other NINDS drug development initiatives.
**Key Requirements and Deliverables**
- The contractor must provide an executive-level Senior Advisor with demonstrable expertise in patient advocacy and drug development.
- The SME will participate as a member of the URGenT ECB, attending up to eight teleconference meetings per year (each lasting approximately one to two hours), as well as ad-hoc milestone or introductory calls for URGenT projects.
- The SME may be required to attend one annual on-site meeting at the NIH campus in Rockville, Maryland.
- The contractor must ensure that all proposed key personnel are employed by the contractor by the start of the contract period.
- Deliverables include strategic feedback, technical guidance, and participation in ECB meetings as outlined in the Statement of Work (Attachment #1).
**Contract Structure and Period of Performance**
- The Government anticipates awarding a fixed-price purchase order with a base period from November 6, 2026, to November 5, 2027, and two option years extending through November 5, 2029.
- Estimated labor is 50 hours per year, with the possibility of up to an additional 50 hours annually.
- The contract allows for reimbursement of up to $2,000 per consultant per year for travel expenses, subject to prior approval.
**Evaluation Criteria**
Quotations will be evaluated based on:
- Technical capability, particularly personnel qualifications (resumes and narrative required).
- Price (using the provided Price Template).
- Relevant past performance (1-2 examples with federal or commercial clients).
**Submission Instructions**
- Responses are limited to ten single-sided pages (excluding resumes, letters of commitment, certifications, and the price template).
- Required attachments include resumes, letters of commitment, completed price template (in Excel), and representations/certifications.
- All offerors must be actively registered in SAM.gov at the time of submission.
- Submissions must include the company’s full name and address, Unique Entity ID (UEI), and contact information for the authorized representative.
- Proposals are due by 1:00 PM Eastern Time on November 2, 2026, and must be submitted electronically to Claudia Ventola, Contracting Officer, at [email protected]. Questions are due by October 30, 2026, at 1:00 PM EST.
**Contract Administration and Compliance**
- The contract incorporates standard FAR and HHSAR clauses and provisions, including those related to key personnel, information security, and accessibility.
- The Key Personnel clause requires prior written consent from the Contracting Officer for any substitutions or changes.
- Salary rates for personnel are capped at the Executive Schedule, Level II, as per NIH policy.
- The contract may not exceed three years in total duration, including all options.
**Place of Performance and Contact Information**
- The primary place of performance is Rockville, Maryland.
- The contracting entity is the OMAS Strategic Buying Center - Professional Services, a federal office under HHS.
- The primary point of contact is Claudia Ventola ([email protected]).
**Special Considerations**
- This procurement is set aside for small businesses.
- The Defense Priorities and Allocations System (DPAS) does not apply.
- All travel must be pre-approved, and only necessary travel will be reimbursed.
- Offerors must adhere to all instructions regarding proposal format, required documentation, and compliance with salary limitations.
**Summary**
This opportunity is ideal for small businesses with proven expertise in scientific and technical consulting, particularly those with executive-level experience in drug development and patient advocacy. The role is critical in shaping the strategic direction of ultra-rare gene-based therapy initiatives at NINDS, offering a unique chance to contribute to high-impact biomedical research and patient-centered program development. Interested contractors should carefully review the Statement of Work and all solicitation attachments to ensure full compliance with submission and qualification requirements.
For full details and access to all attachments, refer to the official notice at: https://sam.gov/opp/e58e04d968d94c408f28ef95e2d6048f/view
Documents7